148 related articles for article (PubMed ID: 36328147)
1. Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.
Zhao Z; Xu H; Wei Y; Sun L; Song Y
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166594. PubMed ID: 36328147
[TBL] [Abstract][Full Text] [Related]
2. An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer.
Li D; Wang M
Aging (Albany NY); 2024 Apr; 16(8):6773-6795. PubMed ID: 38643468
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
[TBL] [Abstract][Full Text] [Related]
5. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.
Sun T; Liu Z; Bi F; Yang Q
Mol Oncol; 2021 Dec; 15(12):3639-3658. PubMed ID: 34382324
[TBL] [Abstract][Full Text] [Related]
7. PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα.
Yang P; Yang X; Wang D; Yang H; Li Z; Zhang C; Zhang S; Zhu J; Li X; Su P; Zhuang T
Oncogene; 2024 Jan; 43(4):248-264. PubMed ID: 38017133
[TBL] [Abstract][Full Text] [Related]
8. Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization.
Yokoyama S; Iwakami Y; Hang Z; Kin R; Zhou Y; Yasuta Y; Takahashi A; Hayakawa Y; Sakurai H
Sci Rep; 2020 Nov; 10(1):19214. PubMed ID: 33154524
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.
Zhu R; Liu Y; Zhou H; Li L; Li Y; Ding F; Cao X; Liu Z
Cancer Lett; 2018 Apr; 418():125-134. PubMed ID: 29331416
[TBL] [Abstract][Full Text] [Related]
10. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into the non-canonical roles of PSMD14/POH1/Rpn11 in proteostasis and in the modulation of cancer progression.
Bustamante HA; Albornoz N; Morselli E; Soza A; Burgos PV
Cell Signal; 2023 Jan; 101():110490. PubMed ID: 36241058
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1.
Li J; Li Y; Xu F; Sun B; Yang L; Wang H
Exp Cell Res; 2022 Jun; 415(2):113148. PubMed ID: 35405117
[TBL] [Abstract][Full Text] [Related]
13. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.
He L; Yu C; Qin S; Zheng E; Liu X; Liu Y; Yu S; Liu Y; Dou X; Shang Z; Wang Y; Wang Y; Zhou X; Liu B; Zhong Y; Liu Z; Lu J; Sun L
Mol Cell; 2023 Nov; 83(22):4000-4016.e6. PubMed ID: 37935198
[TBL] [Abstract][Full Text] [Related]
14. Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4.
Jia C; Zhang X; Qu T; Wu X; Li Y; Zhao Y; Sun L; Wang Q
PeerJ; 2023; 11():e14654. PubMed ID: 36632137
[TBL] [Abstract][Full Text] [Related]
15. Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression.
Wu Y; Jin S; Liu Q; Zhang Y; Ma L; Zhao Z; Yang S; Li YP; Cui J
Autophagy; 2021 Jun; 17(6):1379-1392. PubMed ID: 32476569
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.
Song W; Li Z; Xia M; Xiao W
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975230
[TBL] [Abstract][Full Text] [Related]
17. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
Gong Y; Wei ZR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
[TBL] [Abstract][Full Text] [Related]
18. The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells.
Hu Z; Cai M; Deng L; Zhu L; Gao J; Tan M; Liu J; Lin B
Oncotarget; 2016 Dec; 7(50):82921-82932. PubMed ID: 27863372
[TBL] [Abstract][Full Text] [Related]
19. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.
Zhi T; Jiang K; Xu X; Yu T; Zhou F; Wang Y; Liu N; Zhang J
Neuro Oncol; 2019 Mar; 21(4):462-473. PubMed ID: 30590814
[TBL] [Abstract][Full Text] [Related]
20. The Proteasomal Deubiquitinating Enzyme PSMD14 Regulates Macroautophagy by Controlling Golgi-to-ER Retrograde Transport.
Bustamante HA; Cereceda K; González AE; Valenzuela GE; Cheuquemilla Y; Hernández S; Arias-Muñoz E; Cerda-Troncoso C; Bandau S; Soza A; Kausel G; Kerr B; Mardones GA; Cancino J; Hay RT; Rojas-Fernandez A; Burgos PV
Cells; 2020 Mar; 9(3):. PubMed ID: 32210007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
